• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novartis AG Common Stock (NY:NVS)

123.79 +1.18 (+0.96%)
Official Closing Price Updated: 7:00 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,655,480
Open 123.41
Bid (Size) 122.00 (2)
Ask (Size) 124.65 (2)
Prev. Close 122.61
Today's Range 122.57 - 124.15
52wk Range 96.06 - 133.55
Shares Outstanding N/A
Dividend Yield 3.23%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
The AI Imperative: Why Rapid Upskilling is Non-Negotiable for Pharma’s Future
October 31, 2025
The pharmaceutical sector stands at the precipice of a profound transformation, driven by the relentless march of artificial intelligence (AI) and other advanced technologies. As highlighted by... 
Via TokenRing AI
Topics Artificial Intelligence Economy
AI Revolutionizes Pharma: Smarter Excipients for Safer, More Potent Drugs
October 31, 2025
San Francisco, CA – October 31, 2025 – Artificial intelligence (AI) is ushering in a transformative era for the pharmaceutical industry, particularly in the often-overlooked yet critical domain of... 
Via TokenRing AI
Topics Artificial Intelligence Supply Chain

Performance

YTD
+27.4%
+27.4%
1 Month
-6.0%
-6.0%
3 Month
+7.4%
+7.4%
6 Month
+8.3%
+8.3%
1 Year
+14.2%
+14.2%

More News

Read More
Earnings Scheduled For October 28, 2025
October 28, 2025
Via Benzinga
Dyne Therapeutics Stock Soars After Rival Avidity Biosciences Gets Acquired By Novartis
October 27, 2025
Via Stocktwits
What to Expect from Novartis's Earnings
October 27, 2025
Via Benzinga
AI Revolutionizes Pharma R&D: A New Era of Accelerated Drug Discovery and Personalized Medicine
October 31, 2025
Via TokenRing AI
Topics Artificial Intelligence Intellectual Property
AI: The Pharmaceutical Sector’s New Catalyst for a Healthier Future
October 31, 2025
Via TokenRing AI
Topics Animal Testing Artificial Intelligence Economy
Here's Why Avidity Biosciences Stock Soared This Week (There's More to the Deal Than You Might Think)
October 31, 2025
Via The Motley Fool
Here's My Favorite Passive Income Investment
October 31, 2025
Via The Motley Fool
Topics ETFs
Is the Market Bullish or Bearish on Novartis AG?
October 29, 2025
Via Benzinga
United Therapeutics Dips As Bread-And-Butter Drug Comes Up Short
October 29, 2025
Via Investor's Business Daily
Novartis Slips As Generics Champ At Heart-Failure Drug In Mixed Third Quarter
October 28, 2025
Via Investor's Business Daily
Novartis Maintains Outlook Even As Generics Bite Into Profits
October 28, 2025
Via Benzinga
'Merger Monday' Makes Comeback As US M&A Tops $80 Billion In 24 Hours
October 28, 2025
Via Benzinga
Is It Too Late To Buy Avidity Stock After Novartis Deal?
October 28, 2025
Via Talk Markets
Why Dyne Therapeutics Stock Crushed the Market on Monday
October 27, 2025
Via The Motley Fool
Wall Street Soars as Qualcomm Ignites the AI Race
October 27, 2025
Via Chartmill
Topics Artificial Intelligence Stocks
Why Avidity Biosciences Stock Blasted 42% Higher Today
October 27, 2025
Via The Motley Fool
Avidity Biosciences Soars After $72 Per Share Novartis Takeover
October 27, 2025
Via Benzinga
Qualcomm, Tesla, Intellia Therapeutics, Avidity Biosciences, Dyne Therapeutics: Stocks Making The Biggest Moves Today
October 27, 2025
Via Stocktwits
Topics Artificial Intelligence ETFs Government
Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology
October 27, 2025
Via Investor Brand Network
Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology
October 27, 2025
Via FinancialNewsMedia
Avidity Shareholders Win Big As Novartis Moves Fast On $12 Billion Deal
October 27, 2025
Via Benzinga
Why Avidity Biosciences Stock Is Jumping Over 43% In Premarket Today
October 27, 2025
Via Stocktwits
Stock Market Today: Dow Jones, S&P 500 Futures Climb Ahead Of Busy Week On Wall Street—Novartis, Nucor, Waste Management In Focus
October 27, 2025
Via Benzinga
Topics Stocks

Frequently Asked Questions

Is Novartis AG Common Stock publicly traded?
Yes, Novartis AG Common Stock is publicly traded.
What exchange does Novartis AG Common Stock trade on?
Novartis AG Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novartis AG Common Stock?
The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
What is the current price of Novartis AG Common Stock?
The current price of Novartis AG Common Stock is 123.79
When was Novartis AG Common Stock last traded?
The last trade of Novartis AG Common Stock was at 10/31/25 07:00 PM ET
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap